Loading
Eastman Chemical Co Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by SMITH BRIAN TRAVIS, was filed 29 Aug 2025.
Insider Decl.
602
Thresholds
n/a
Buy Volume
€3M
12 ops. · all time
Sell Volume
€120M
134 ops. · all time
Who traded when
BuySaleMark J. Costa1 buy4 sales
Adrian James Holt3 sales
Brad A. Lich1 buy2 sales
Stephen Glenn Crawford3 sales
Julie A. McAlindon1 buy1 sale
William Thomas McLain Jr.1 buy1 sale
+9 other insiders
Since the insiders bought
- +4.4%Entry US$69.42 · Close at T+365 US$72.44
- +3.0%Entry US$70.34 · Close at T+365 US$72.44
- +3.0%Entry US$70.34 · Close at T+365 US$72.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Eastman Chemical Co Buy (bullish), based on 16 analysts. Average price target: US$75.31.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 11,719 of 26,248 companies
54.3
score / 100
Value67
Quality41
FCF yld5.8%
Earn yld6.5%
EV/EBITDA9.3x
ROE7.3%
Gross mgn21%
Net mgn5.4%
Debt/EBITDA3.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$63.50
Analyst consensus
16 analystsBuy
US$65.00Target US$75.31(+19%)US$85.00
Income statement
RevenueUS$8.8B
Gross profitUS$1.8B21% margin
EBITDAUS$1.3B15% margin
Net incomeUS$474M5.0% margin
Valuation
PER (trailing)16.6x
PER (forward)9.6x
P/Book1.2x
Beta1.08
Balance sheet & cash
Market capUS$7.3B
Total debtUS$4.8B
Free Cash FlowUS$424M
Debt / Equity89%
Profitability & ownership
ROE7.3%
ROA3.5%
% insiders0.9%
% institutions95.5%
Last declaration on 3 September 2026
Declarations602 total
5,378 shares0Common StockSEC:0000915389-26-000145:0
2,482 shares0Common StockSEC:0000915389-26-000145:1
7,860 shares0Common StockSEC:0000915389-26-000145:2
3,283 shares@ US$71.310.0030% mcap15.2% of flowCommon StockSEC:0000915389-26-000142:0
3,283 shares@ US$71.31180.0030% mcap15.2% of flowCommonSEC144:0001959173-26-005595
25,260 shares@ US$80.268.4% of flowCommon StockSEC:0000915389-26-000042:0
4,720 shares@ US$80.269.9% of flowCommon StockSEC:0000915389-26-000041:0
5,569 shares@ US$80.267.6% of flowCommon StockSEC:0000915389-26-000049:0
588 shares@ US$80.263.0% of flowCommon StockSEC:0000915389-26-000048:0
3,086 shares@ US$80.2657.3% of flowCommon StockSEC:0000915389-26-000047:0
1,812 shares@ US$80.2617.5% of flowCommon StockSEC:0000915389-26-000046:0
528 shares@ US$80.2627.9% of flowCommon StockSEC:0000915389-26-000045:0
1,063 shares@ US$80.2686.9% of flowCommon StockSEC:0000915389-26-000044:0
4,471 shares@ US$80.2629.4% of flowCommon StockSEC:0000915389-26-000043:0
18,861 shares0Common StockSEC:0000915389-26-000031:0
64,192 shares0Common StockSEC:0000915389-26-000027:0
10,589 shares0Common StockSEC:0000915389-26-000024:0
15,883 shares0Common StockSEC:0000915389-26-000030:0
12,133 shares0Common StockSEC:0000915389-26-000029:0
3,309 shares0Common StockSEC:0000915389-26-000028:0
7,280 shares0Common StockSEC:0000915389-26-000026:0
1,937 shares0Common StockSEC:0000915389-26-000025:0
2,297 shares0Common StockSEC:0000915389-26-000023:0
43,638 shares@ US$78.492.8% of flowCommon StockSEC:0001364708-26-000003:1
2,636 shares@ US$78.496.5% of flowCommon StockSEC:0001805013-26-000002:1
25 of 602 declarations
About Eastman Chemical Co
On August 27, 2025, 11 Eastman Chemical Co insiders bought on the same day for EUR 1,669,762, including Mark J. Costa (CEO & Board Chair) for EUR 431,308 and William Thomas McLain Jr. (EVP, CFO) for EUR 216,552. The largest purchase in the record is nonetheless David W. Raisbeck's (Director), EUR 868,885 on December 7, 2018. The 12 purchases total EUR 2,538,647 (median EUR 110,085), against 134 sales worth EUR 119,724,230 (median EUR 402,464), or 8% purchases among open-market trades.
The three largest sales are all Mark J. Costa's: EUR 9,598,504 on May 7, 2024, EUR 8,798,306 on November 26, 2024 and EUR 4,420,914 on August 12, 2021. Costa also files the most, 61, ahead of Brad A. Lich (EVP & CCO, 54) and Scott King V (CAO & Controller, 47).
Read moreShow less
The 602 filings from 40 insiders were published from February 23, 2016 to September 3, 2026, with 315 grants and 119 option exercises. 2021 is the busiest year (89), ahead of 2018 (83) and 2024 (75). Over the last twelve months: 27 filings, no purchase, 1 sale. The median delay is 2 days.
For 12 purchases with a stored 90-day result, the median is -11.7% and 8% are positive: stored past results, not a forecast. This US chemicals and materials company is worth USD 7.3 billion; insiders hold 0.9% of the capital.
